Your browser doesn't support javascript.
loading
Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer.
Nath, Arijit; Mitra, Soham; Mistry, Tanuma; Pal, Ranita; Nasare, Vilas D.
Afiliación
  • Nath A; Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha, 751024, India.
  • Mitra S; Department of Biotechnology and Medical Engineering, National Institute of Technology, Rourkela, Odisha, 769008, India.
  • Mistry T; Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata, 700026, India.
  • Pal R; Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata, 700026, India.
  • Nasare VD; Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata, 700026, India. vilas.dr@gmail.com.
Med Oncol ; 39(1): 14, 2021 Nov 23.
Article en En | MEDLINE | ID: mdl-34812991
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Neoplasias de la Mama Triple Negativas / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Med Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Neoplasias de la Mama Triple Negativas / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Med Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article